Sparrow Bio

Sparrow Bio has developed what it claims to be the world’s first $100 personal DNA analyzer. Their breakthrough technology aims to bring lab-grade accuracy (comparable to PCR) into the home setting at a fraction of traditional costs. The founder and team have experience in bringing multiple diagnostic products through regulatory approval and clinical validation in major journals. No clinical trial results are cited for specific disease applications as this is a diagnostic device/platform rather than a therapeutic product. The company’s founder has previously raised $50M in financing and co-invented the widely used DNA spit cup for consumer genomics companies like 23andMe and Ancestry.com.